RAD21
Double-strand-break repair protein rad21 homolog
Also known as: hHR21, KIAA0078, RAD21_HUMAN, SCC1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60216
- Gene
- RAD21
- Ensembl
- ENSG00000164754
- Chromosome
- 8
- Canonical length
- 631 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene is highly similar to the gene product of Schizosaccharomyces pombe rad21, a gene involved in the repair of DNA double-strand breaks, as well as in chromatid cohesion during mitosis. This protein is a nuclear phospho-protein, which becomes hyperphosphorylated in cell cycle M phase. The highly regulated association of this protein with mitotic chromatin specifically at the centromere region suggests its role in sister chromatid cohesion in mitotic cells. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
631 residues, UniProt reviewed canonical sequence.
>O60216|RAD21
1 MFYAHFVLSK RGPLAKIWLA AHWDKKLTKA HVFECNLESS VESIISPKVK MALRTSGHLL
61 LGVVRIYHRK AKYLLADCNE AFIKIKMAFR PGVVDLPEEN REAAYNAITL PEEFHDFDQP
121 LPDLDDIDVA QQFSLNQSRV EEITMREEVG NISILQENDF GDFGMDDREI MREGSAFEDD
181 DMLVSTTTSN LLLESEQSTS NLNEKINHLE YEDQYKDDNF GEGNDGGILD DKLISNNDGG
241 IFDDPPALSE AGVMLPEQPA HDDMDEDDNV SMGGPDSPDS VDPVEPMPTM TDQTTLVPNE
301 EEAFALEPID ITVKETKAKR KRKLIVDSVK ELDSKTIRAQ LSDYSDIVTT LDLAPPTKKL
361 MMWKETGGVE KLFSLPAQPL WNNRLLKLFT RCLTPLVPED LRKRRKGGEA DNLDEFLKEF
421 ENPEVPREDQ QQQHQQRDVI DEPIIEEPSR LQESVMEASR TNIDESAMPP PPPQGVKRKA
481 GQIDPEPVMP PQQVEQMEIP PVELPPEEPP NICQLIPELE LLPEKEKEKE KEKEDDEEEE
541 DEDASGGDQD QEERRWNKRT QQMLHGLQRA LAKTGAESIS LLELCRNTNR KQAAAKFYSF
601 LVLKKQQAIE LTQEEPYSDI IATPGPRFHI ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against RAD21 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 151 nTPM
Expression across tissuesHPA
Tissue
- thymus: 151 nTPM
- bone marrow: 116 nTPM
- tonsil: 102 nTPM
- lymph node: 102 nTPM
- tongue: 87 nTPM
- retina: 85 nTPM
Single-cell type
- late spermatids: 737 nCPM
- monocyte progenitors: 382 nCPM
- neutrophils: 364 nCPM
- early spermatids: 356 nCPM
- neutrophil progenitors: 289 nCPM
- erythrocyte progenitors: 285 nCPM
Immune cell
- T-reg: 32 nTPM
- basophil: 29 nTPM
- neutrophil: 22 nTPM
- eosinophil: 22 nTPM
- naive CD4 T-cell: 15 nTPM
- memory CD8 T-cell: 15 nTPM
Brain region
- white matter: 132 nTPM
- hypothalamus: 107 nTPM
- medulla oblongata: 100 nTPM
- spinal cord: 100 nTPM
- cerebellum: 97 nTPM
- basal ganglia: 97 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RAD21.
Disease | AllUniProt
Conditions RAD21 is implicated in, by any mechanism.
- Cornelia de Lange syndrome 4 with or without midline brain defects (CDLS4) MIM:614701
- Mungan syndrome (MGS) MIM:611376
Disease | GeneticClinVar
59 pathogenic / likely-pathogenic of 534 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cornelia de Lange syndrome 4
- Inborn genetic diseases
- RAD21-related disorder
- Mungan syndrome
- Acute megakaryoblastic leukemia in down syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.64
- DepMap mean gene effect
- -1.48
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 18% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cell division
- chromatin looping
- chromosome segregation
- DNA recombination
- double-strand break repair
- establishment of meiotic sister chromatid cohesion
- establishment of mitotic sister chromatid cohesion
- negative regulation of G2/M transition of mitotic cell cycle
- negative regulation of glial cell apoptotic process
- negative regulation of interleukin-1 beta production
- negative regulation of mitotic metaphase/anaphase transition
- negative regulation of neuron apoptotic process
- negative regulation of tumor necrosis factor production
- positive regulation of interleukin-10 production
- positive regulation of sister chromatid cohesion
- protein localization to chromatin
- reciprocal meiotic recombination
- regulation of transcription by RNA polymerase II
- replication-born double-strand break repair via sister chromatid exchange
- response to hypoxia
- sister chromatid cohesion
Molecular functions
- chromatin binding
- cis-regulatory region sequence-specific DNA binding
- DNA-binding transcription factor binding
- lncRNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RAD21 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RAD21 as an antibody target. Whether an autoantibody or antibody against RAD21 could matter depends on whether native RAD21 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RAD21 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RAD21 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...